| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6064631 | Journal of Allergy and Clinical Immunology | 2014 | 21 Pages |
Abstract
MrgX2 might be a new target molecule for the treatment of wheal reactions in patients with severe CU.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Daisuke MD, Jun-ichi PhD, Hirohito MD, PhD, Yusuke MSc, Yasushi PhD, Tomomi BSc, Kazumichi PhD, Satoshi PhD, Koremasa MD, PhD, Tadashi MD, PhD, Chisei MD, PhD, Yoshimichi MD, PhD,